434 related articles for article (PubMed ID: 18649106)
21. A reliable risk score for stage IV esophagogastric cancer.
Blank S; Lordick F; Dobritz M; Grenacher L; Burian M; Langer R; Roth W; Schaible A; Becker K; Bläker H; Sisic L; Stange A; Compani P; Schulze-Bergkamen H; Jäger D; Büchler M; Siewert JR; Ott K
Eur J Surg Oncol; 2013 Aug; 39(8):823-30. PubMed ID: 23375470
[TBL] [Abstract][Full Text] [Related]
22. Positive peritoneal lavage cytology is a predictor of worse survival in locally advanced pancreatic cancer.
Clark CJ; Traverso LW
Am J Surg; 2010 May; 199(5):657-62. PubMed ID: 20466112
[TBL] [Abstract][Full Text] [Related]
23. Stage-specific effect of adjuvant therapy following gastric cancer resection: a population-based analysis of 4,041 patients.
Coburn NG; Govindarajan A; Law CH; Guller U; Kiss A; Ringash J; Swallow CJ; Baxter NN
Ann Surg Oncol; 2008 Feb; 15(2):500-7. PubMed ID: 18026800
[TBL] [Abstract][Full Text] [Related]
24. Preoperative intraperitoneal chemotherapy for patients with serosa-infiltrating gastric cancer.
Yano M; Yasuda T; Fujiwara Y; Takiguchi S; Miyata H; Monden M
J Surg Oncol; 2004 Oct; 88(1):39-43. PubMed ID: 15384086
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcomes and survival after laparoscopy-assisted distal gastrectomy for gastric cancer: three-year survival analysis of a single-center experience in Korea.
Yoo HM; Lee HH; Shim JH; Jeon HM; Park CH; Kim JG; Song KY
J Surg Oncol; 2011 Oct; 104(5):511-5. PubMed ID: 21618247
[TBL] [Abstract][Full Text] [Related]
26. Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas.
Meszoely IM; Lee JS; Watson JC; Meyers M; Wang H; Hoffman JP
Am Surg; 2004 Mar; 70(3):208-13; discussion 213-4. PubMed ID: 15055843
[TBL] [Abstract][Full Text] [Related]
27. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
[TBL] [Abstract][Full Text] [Related]
28. Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a canadian cancer center.
Gill S; Shah A; Le N; Cook EF; Yoshida EM
J Clin Oncol; 2003 Jun; 21(11):2070-6. PubMed ID: 12775731
[TBL] [Abstract][Full Text] [Related]
29. Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States.
Sherman KL; Merkow RP; Bilimoria KY; Wang CE; Mulcahy MF; Benson AB; Bentrem DJ
Ann Surg Oncol; 2013 Feb; 20(2):362-70. PubMed ID: 22890592
[TBL] [Abstract][Full Text] [Related]
30. Interaction of splenectomy and perioperative blood transfusions on prognosis of patients with proximal gastric and gastroesophageal junction cancer.
Weitz J; D'Angelica M; Gonen M; Klimstra D; Coit DG; Brennan MF; Karpeh MS
J Clin Oncol; 2003 Dec; 21(24):4597-603. PubMed ID: 14673048
[TBL] [Abstract][Full Text] [Related]
31. Survival in lymph node negative adenocarcinoma of the esophagus after R0 resection with and without neoadjuvant therapy: evidence for downstaging of N status.
Leers JM; Ayazi S; Hagen JA; Terterov S; Klipfel N; Oezcelik A; Abate E; Lipham JC; DeMeester SR; Banki F; DeMeester TR
J Am Coll Surg; 2009 Apr; 208(4):553-6. PubMed ID: 19476789
[TBL] [Abstract][Full Text] [Related]
32. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
Gallagher DJ; Zheng J; Capanu M; Haviland D; Paty P; Dematteo RP; D'Angelica M; Fong Y; Jarnagin WR; Allen PJ; Kemeny N
Ann Surg Oncol; 2009 Jul; 16(7):1844-51. PubMed ID: 19224284
[TBL] [Abstract][Full Text] [Related]
33. Management protocol for scirrhous gastric cancer.
Ikeguchi M; Yamamoto O; Kaibara N
In Vivo; 2004; 18(5):577-80. PubMed ID: 15523896
[TBL] [Abstract][Full Text] [Related]
34. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma.
Pedrazzani C; de Manzoni G; Marrelli D; Giacopuzzi S; Corso G; Minicozzi AM; Rampone B; Roviello F
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):378-85. PubMed ID: 17662776
[TBL] [Abstract][Full Text] [Related]
35. Yield of Staging Laparoscopy and Lavage Cytology for Radiologically Occult Peritoneal Carcinomatosis of Gastric Cancer.
Ikoma N; Blum M; Chiang YJ; Estrella JS; Roy-Chowdhuri S; Fournier K; Mansfield P; Ajani JA; Badgwell BD
Ann Surg Oncol; 2016 Dec; 23(13):4332-4337. PubMed ID: 27384751
[TBL] [Abstract][Full Text] [Related]
36. The critical role of peritoneal cytology in the staging of gastric cancer: an evidence-based review.
De Andrade JP; Mezhir JJ
J Surg Oncol; 2014 Sep; 110(3):291-7. PubMed ID: 24850538
[TBL] [Abstract][Full Text] [Related]
37. Gastric adenocarcinoma with distant metastasis: is gastrectomy necessary?
Sarela AI; Yelluri S;
Arch Surg; 2007 Feb; 142(2):143-9; discussion 149. PubMed ID: 17309965
[TBL] [Abstract][Full Text] [Related]
38. Peritoneal lavage cytology in patients with oesophagogastric adenocarcinoma.
Nath J; Moorthy K; Taniere P; Hallissey M; Alderson D
Br J Surg; 2008 Jun; 95(6):721-6. PubMed ID: 18412292
[TBL] [Abstract][Full Text] [Related]
39. Chemoradiation therapy for potentially resectable gastric cancer: clinical outcomes among patients who do not undergo planned surgery.
Kim MM; Mansfield PF; Das P; Janjan NA; Badgwell BD; Phan AT; Delclos ME; Maru D; Ajani JA; Crane CH; Krishnan S
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):167-72. PubMed ID: 18406886
[TBL] [Abstract][Full Text] [Related]
40. [Strategy for patients with cytology positive and peritoneal dissemination from gastric cancer].
Yabusaki H; Nashimoto A; Nakagawa S
Gan To Kagaku Ryoho; 2007 Nov; 34(12):1934-6. PubMed ID: 18219857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
